Phase 2 Clinical Trial for Venous Leg Ulcers Nears Completion

World News: . []

BRISBANE Australia Sept 05 2018 GLOBE NEWSWIRE) -- Factor Therapeutics Limited ASX FTT the “Company”), an Australian biomedical company developing therapeutics for advanced wound care is pleased to announce that the Companys Phase 2 clini...

More news and information about Factor Therapeutics

Published By:

Globe Newswire: 01:00 GMT Thursday 6th September 2018

Published: .

Search for other references to "phase" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us